Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern? - Wikidata - awgldk - TriplyDB

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

http://www.wikidata.org/entity/Q38925780

about

No evidence for a direct role of HLA-B27 in pathological bone formation in axial SpA.Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis.

P2860

Q40063353-1C0C61AF-7781-413A-9C53-9C0F3DDEB0B4 Q50127590-DA6E8705-AFB9-4961-90BE-7E372ACB2F0F

P2860

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

http://www.wikidata.org/entity/Q38925780

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

@en

type

label

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

@en

prefLabel

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

@en

P1433

Q38925780-A1207C25-D9A3-49AA-B6C0-C5FDF8AAA326

P1476

Q38925780-3F60C5C4-206E-46CB-8954-B47B02C49882

P2093

Q38925780-BAD012DB-5FE5-4496-9EDB-0DBA84FC2C9A

P2860

Q38925780-01E51C6A-8AF6-4FF6-9645-85069A54855F

Q38925780-085A272F-303B-4DD4-B0C7-BD3BB392BE63

Q38925780-0E0A8040-41D9-40B9-A116-C3FDCC47C34D

Q38925780-12254CA4-2A61-4D79-B18A-C409C8E25985

Q38925780-13ED8779-8975-4806-AAAF-0F876D9262DD

Q38925780-15194601-7C48-4E90-83FE-72AD108F3461

Q38925780-25B8302D-F513-4383-A8D8-8D429455800B

Q38925780-38E73961-45AF-49C0-BE2B-15F7713E8FBC

Q38925780-3B952783-361A-49A2-B682-B9024EC24C88

Q38925780-42103FD3-47F2-4BE5-B161-39E2E86C6359

P2888

Q38925780-D46612C2-C349-428D-A3F9-98D25CB87D74

P304

Q38925780-DC1151A9-9B09-4707-AF56-3380A608D096

P31

Q38925780-3E074590-9FFA-4AA1-A93A-CCDFC1DA56EF

P356

Q38925780-A81780BB-00B8-4EAB-BA7C-4965648BD58C

P433

Q38925780-859F664E-7ED5-4597-A1C7-5ACB5BE7D815

P478

Q38925780-090D4E76-E48F-4794-9D95-9375BC7944B2

P50

Q38925780-E3DBEB40-2982-4A97-BE1E-63C3351F99F4

P577

Q38925780-7159EEBF-A182-44E4-85AD-72BFF3607CAB

P6179

Q38925780-3020DB7C-9825-4993-A092-B06F1227DF04

P698

Q38925780-C044B53C-8942-48C2-9CE9-8FBCB0C2D144

P356

S11926-017-0639-7

P1433

Current Rheumatology Reports

P1476

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

@en

P2093

Barbara Neerinckx

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial.

Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis.

Vertebrate skeletogenesis

Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis.

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis.

IL-17-producing γδ T cells enhance bone regeneration.

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

P2888

s11926-017-0639-7

P304

14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-017-0639-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084033471

http://www.w3.org/2001/XMLSchema#string

P698

28265849

http://www.w3.org/2001/XMLSchema#string